Mehreen S. Datoo
0000-0003-4968-2842
Oxford University
1 paper found
Refreshing results…
Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya
Missing publications? Search for publications with a matching author name.